In the UK, he has been elected President of the Renal Association for the term 2012 2014. Dr Wheeler has served on the editorial boards of American Journal of Kidney Diseases and Journal of the American Society of Nephrology and is presently Co-Editor for Nephrology Dialysis Transplantation. Advisor/Consultant: Amgen Honoraria: Abbott; Amgen; Fresenius; Otsuka; Shire Travel Stipend: Amgen; Merck Sharp & Dohme; Shire Grant/Research Support: Abbott; Genzyme Dick de Zeeuw, MD, PhD, earned his MD from the University of Groningen in 1975. He completed his PhD thesis in 1980 on the topic of renal hypertension at the Renal Department of the Groningen University. He later obtained training in clinical and experimental renal research at the Renal Department in Groningen and clinical pharmacology at the University of Dallas (1984 1985) and was board certified in 1996 at the University of Groningen. Dr de Zeeuw is currently Professor and Chair of the Department of Clinical Pharmacology with a joint appointment in the Department of Nephrology. He has served on the editorial board of several international journals, including Clinical Nephrology, Current Opinion in Nephrology and Hypertension, Journal of Geriatric Urology and Nephrology, Journal of Hypertension, Journal of the Renin-Angiotensin-Aldosterone System, Kidney International, NDT Plus, and Nephron. Dr de Zeeuw is Director of the Groningen University Institute for Drug Exploration (GUIDE), and member of ISN Council. His research interests include: optimizing current therapies and finding new therapeutical approaches to reduce the progressive loss of cardiovascular and renal function, both in diabetic and non-diabetic renal disease. 